咽后壁注射治疗成人腭咽功能障碍的疗效
回顾性分析2018至2023年一家三级喉科中心29例接受咽后壁注射的成人患者,共67次注射。全队列VHI-10变化评分为3.87(-6.85至-0.89,p=0.012),EAT-10为-3.00(-4.75至-1.25,p=0.001),但同期行嗓音和/或吞咽手术的亚组中未达统计学显著。作者认为咽后壁注射对腭咽功能障碍患者的吞咽困难和发声困难似乎有治疗作用,但许多患者存在多因素损害,需进一步研究。
要点
- 咽后壁注射后全队列VHI-10变化评分为3.87(-6.85至-0.89,p=0.012)。
- 全队列EAT-10变化评分为-3.00(-4.75至-1.25,p=0.001)。
- 同期行嗓音和/或吞咽手术的亚组中上述变化未达统计学显著。
核心结论
- 咽后壁注射对腭咽功能障碍患者的吞咽困难和发声困难似乎有治疗作用,但许多患者存在多因素损害。
- 作者认为需进一步研究以确定咽后壁注射与其他手术同期进行时在该复杂患者群体中的获益。
研究设计与样本
- 回顾性病历审查,纳入2018至2023年一家三级喉科中心接受咽后壁注射的患者。
- 共29例患者(11例女性),平均年龄59.4±17.0岁,共行67次咽后壁注射。
- 病因包括头颈癌(n=23)和神经系统疾病(n=6)。
- 30次咽后壁注射同期行上食管括约肌干预(25次扩张、3次肌切开、2次肉毒毒素注射),8次同期行声门手术(6次声带注射、2次甲状软骨成形术)。
- 证据等级为4级(病例系列)。
主要发现
- 全队列VHI-10变化评分为3.87(-6.85至-0.89,p=0.012),与0相比有统计学差异。
- 全队列EAT-10变化评分为-3.00(-4.75至-1.25,p=0.001),与0相比有统计学差异。
- 同期行嗓音和/或吞咽手术的亚组中,VHI-10和EAT-10变化评分与0相比未达统计学显著。
- 咽后壁注射后改良钡餐吞咽检查中软腭闭合评分趋于更好,但未达统计学显著。
- 注射后过度鼻音和可闻及鼻漏气均改善。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出需进一步研究以确定咽后壁注射与其他手术同期进行时在该复杂患者群体中的获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE(S): Posterior pharyngeal wall (PPW) injection is often employed to treat velopharyngeal deficiency (VPD). We sought to analyze the impact of PPW injection on severity of dysphagia and dysphonia. METHODS: Retrospective chart review was conducted of patients undergoing PPW injection from 2018 to 2023 at a tertiary laryngology center. Effects on Voice Handicap Index-10 (VHI-10), Eating Assessment Tool-10 (EAT-10), soft palate closure on modified barium swallow, and auditory-perceptual measures of hypernasality and audible nasal air emission were analyzed. RESULTS: 67 PPW injections were performed in 29 patients (11 female). Mean age was 59.4 ± 17.0 years. Etiologies were head and neck cancer (n = 23) and neurologic conditions (n = 6). 30 PPW injections were performed concurrent with intervention on the upper esophageal sphincter (25 dilations, 3 myotomies, 2 botulinum toxin injections), and 8 with a glottic procedure (6 vocal fold injections, 2 thyroplasties). Change scores were 3.87 (-6.85 to -0.89, p = .012) for VHI-10 and -3.00 (-4.75 to -1.25, p = 0.001) for EAT-10. These were statistically different from 0 for the whole cohort but not in the subset of patients undergoing concurrent voice and/or swallow surgery. Soft palate closure scores tended to be better (but not statistically significant) on MBS after PPW injection. Hypernasality and audible nasal air emission both improved after injection. CONCLUSION: PPW injection appears to have a therapeutic effect on dysphagia/dysphonia in patients with VPD; however, many patients have multifactorial impairment. Additional study is needed to determine benefit of PPW when performed in conjunction with other procedures in this complex patient population. LEVEL OF EVIDENCE: 4 (Case series) Laryngoscope, 135:605-613, 2025.
引用
- Arora N, Young VN, Schneider SL, et al. Efficacy of Posterior Pharyngeal Wall Injection for Velopharyngeal Dysfunction in Adults. Laryngoscope. 2024. PMID: 39340343. doi:10.1002/lary.31788
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。